Moses Michael A, Addison Patrick D, Neligan Peter C, Ashrafpour Homa, Huang Ning, Zair Murtuza, Rassuli Alispasha, Forrest Christopher R, Grover Gary J, Pang Cho Y
Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H559-67. doi: 10.1152/ajpheart.00845.2004. Epub 2004 Sep 30.
We previously demonstrated in the pig that instigation of three cycles of 10 min of occlusion and reperfusion in a hindlimb by tourniquet application (approximately 300 mmHg) elicited protection against ischemia-reperfusion injury (infarction) in multiple distant skeletal muscles subsequently subjected to 4 h of ischemia and 48 h of reperfusion, but the mechanism was not studied. The aim of this project was to test our hypothesis that mitochondrial ATP-sensitive potassium (KATP) (mKATP) channels play a central role in the trigger and mediator mechanisms of hindlimb remote ischemic preconditioning (IPC) of skeletal muscle against infarction in the pig. We observed in the pig that hindlimb remote IPC reduced the infarct size of latissimus dorsi (LD) muscle flaps (8 x 13 cm) from 45 +/- 2% to 22 +/- 3% (n = 10; P < 0.05). The nonselective KATP channel inhibitor glibenclamide (0.3 mg/kg) or the selective mKATP channel inhibitor 5-hydroxydecanoate (5-HD, 5 mg/kg), but not the selective sarcolemmal KATP (sKATP) channel inhibitor HMR-1098 (3 mg/kg), abolished the infarct-protective effect of hindlimb remote IPC in LD muscle flaps (n = 10, P < 0.05) when these drugs were injected intravenously at 10 min before remote IPC. In addition, intravenous bolus injection of glibenclamide (1 mg/kg) or 5-HD (10 mg/kg) at the end of hindlimb remote IPC also abolished the infarct protection in LD muscle flaps (n = 10; P < 0.05). Furthermore, intravenous injection of the specific mKATPchannel opener BMS-191095 (2 mg/kg) at 10 min before 4 h of ischemia protected the LD muscle flap against infarction to a similar extent as hindlimb remote IPC, and this infarct-protective effect of BMS-191095 was abolished by intravenous bolus injection of 5-HD (5 mg/kg) at 10 min before or after intravenous injection of BMS-191095 (n = 10; P < 0.05). The infarct protective effect of BMS-191095 was associated with a higher muscle content of ATP at the end of 4 h of ischemia and a decrease in muscle neutrophilic myeloperoxidase activity at the end of 1.5 h of reperfusion compared with the time-matched control (n = 10, P < 0.05). These observations led us to conclude that mKATP channels play a central role in the trigger and mediator mechanisms of hindlimb remote IPC of skeletal muscle against infarction in the pig, and the opening of mKATP channels in ischemic skeletal muscle is associated with an ATP-sparing effect during sustained ischemia and attenuation of neutrophil accumulation during reperfusion.
我们之前在猪身上证明,通过应用止血带(约300 mmHg)在一条后肢进行三个周期的10分钟阻断和再灌注,可使随后经历4小时缺血和48小时再灌注的多个远处骨骼肌免受缺血-再灌注损伤(梗死),但未对其机制进行研究。本项目的目的是验证我们的假设,即线粒体ATP敏感性钾(KATP)(mKATP)通道在猪骨骼肌后肢远程缺血预处理(IPC)对抗梗死的触发和介导机制中起核心作用。我们在猪身上观察到,后肢远程IPC使背阔肌(LD)肌瓣(8×13 cm)的梗死面积从45±2%降至22±3%(n = 10;P < 0.05)。非选择性KATP通道抑制剂格列本脲(0.3 mg/kg)或选择性mKATP通道抑制剂5-羟基癸酸(5-HD,5 mg/kg),而非选择性肌膜KATP(sKATP)通道抑制剂HMR-1098(3 mg/kg),在远程IPC前10分钟静脉注射时,消除了后肢远程IPC对LD肌瓣的梗死保护作用(n = 10,P < 0.05)。此外,在后肢远程IPC结束时静脉推注格列本脲(1 mg/kg)或5-HD(10 mg/kg)也消除了LD肌瓣的梗死保护作用(n = 10;P < 0.05)。此外,在缺血4小时前10分钟静脉注射特异性mKATP通道开放剂BMS-191095(2 mg/kg),对LD肌瓣的梗死保护程度与后肢远程IPC相似,且在静脉注射BMS-191095前或后10分钟静脉推注5-HD(5 mg/kg)可消除BMS-191095的这种梗死保护作用(n = 10;P < 0.05)。与时间匹配的对照组相比,BMS-191095的梗死保护作用与缺血4小时结束时较高的肌肉ATP含量以及再灌注1.5小时结束时肌肉中性粒细胞髓过氧化物酶活性降低有关(n = 10,P < 0.05)。这些观察结果使我们得出结论,mKATP通道在猪骨骼肌后肢远程IPC对抗梗死的触发和介导机制中起核心作用,缺血骨骼肌中mKATP通道的开放与持续缺血期间的ATP节省效应以及再灌注期间中性粒细胞积聚的减轻有关。